L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase.
SD Young, SF Britcher, LO Tran, LS Payne…
Index: Antimicrobial Agents and Chemotherapy, , vol. 39, # 12 p. 2602 - 2605
Full Text: HTML
Citation Number: 481
Abstract
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. ... possible that the NNRTIs can be effective when they are used in combination with additional antiretroviral agents such as ... in a greater degree of initial viral suppression than that which can be mediated by a single agent. ...
Related Articles:
Practical asymmetric synthesis of efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor
[Pierce, Michael E.; Parsons Jr., Rodney L.; Radesca, Lilian A.; Lo, Young S.; Silverman, Stuart; Moore, James R.; Islam, Qamrul; Choudhury, Anusuya; Fortunak, Joseph M. D.; Nguyen, Dieu; Luo, Chi; Morgan, Susan J.; Davis, Wayne P.; Confalone, Pat N.; Chen, Cheng-Yi; Tillyer, Richard D.; Frey, Lisa; Tan, Lushi; Xu, Feng; Zhao, Dalian; Thompson, Andrew S.; Corley, Edward G.; Grabowski, Edward J. J.; Reamer, Robert; Reider, Paul J. Journal of Organic Chemistry, 1998 , vol. 63, # 23 p. 8536 - 8543]
[Kawai, Hiroyuki; Kitayama, Takashi; Tokunaga, Etsuko; Shibata, Norio European Journal of Organic Chemistry, 2011 , # 30 p. 5959 - 5961]
[Thompson, Andrew S.; Corley, Edward G.; Huntington, Martha F.; Grabowski, E. J. J. Tetrahedron Letters, 1995 , vol. 36, # 49 p. 8937 - 8940]
[European Journal of Organic Chemistry, , # 30 p. 5959 - 5961]
Practical asymmetric synthesis of efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor
[Journal of Organic Chemistry, , vol. 63, # 23 p. 8536 - 8543]